Seeing Is Believing
Currently out of the existing stock ratings of Ryan Blicker, 6 are a BUY (100%).
Analyst Ryan Blicker, carries an average stock price target met ratio of 100% that have a potential upside of 11.66% achieved within 66 days. Previously, Ryan Blicker worked at TD COWEN.
Ryan Blicker’s has documented 15 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on DXCM, DexCom at 07-Jul-2020.
Analyst best performing recommendations are on DXCM (DEXCOM).
The best stock recommendation documented was for DXCM (DEXCOM) at 4/1/2020. The price target of $75 was fulfilled within 15 days with a profit of $11.3 (17.74%) receiving and performance score of 11.83.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 15-Jul-2022
$86
$17.57 (25.68%)
$86
7 days ago
(09-Jan-2026)
2/4 (50%)
$17.57 (25.68%)
97
Buy
Since 29-Oct-2021
$78
$9.57 (13.99%)
$100
30 days ago
(17-Dec-2025)
1/4 (25%)
$12.25 (18.63%)
28
Hold
Since 18-Oct-2022
$80
$11.57 (16.91%)
$98
2 months 13 days ago
(03-Nov-2025)
5/9 (55.56%)
$19.57 (32.38%)
61
Buy
Since 09-Feb-2024
$99
$30.57 (44.67%)
$106
2 months 16 days ago
(31-Oct-2025)
0/8 (0%)
$40.78 (70.04%)
Buy
Since 11-Feb-2022
$84
$15.57 (22.75%)
$160
2 months 16 days ago
(31-Oct-2025)
4/6 (66.67%)
$25.78 (44.28%)
231
What Year was the first public recommendation made by Ryan Blicker?